Triclosan targets lipid synthesis.
McMurry
L M
LM
Oethinger
M
M
Levy
S B
SB
D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics; D050753:Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); D004791:Enzyme Inhibitors / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D017354:Point Mutation; D014260:Triclosan / Q000494:pharmacology*
D000891:Anti-Infective Agents, Local; D004791:Enzyme Inhibitors; D008055:Lipids; D014260:Triclosan; D010088:Oxidoreductases; D050753:Enoyl-(Acyl-Carrier-Protein) Reductase (NADH)